Does the MMR triple vaccine cause autism?

Evidence-Based Healthcare and Public Health

Volumn 8, Issue 5, 2004, Pages 239-245

  Sengupta, N ^a   Bedford, H ^b   Elliman, D ^c   Booy, R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Hospital for Sick Children   (United Kingdom)

Author keywords

Aetiology; Autism; Measles; MMR; Mumps; Risk; Rubella; Systematic review

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES MUMPS VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE;

AUTISM; CHILD; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; ENTEROCOLITIS; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; IMMUNITY; IMMUNIZATION; MEASLES; MUMPS; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RUBELLA; VACCINATION;

EID: 14544274080     PISSN: 17442249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehbc.2004.08.004     Document Type: Note

References (52)

1. D.L. Miller Frequency of complications of measles, 1963. Report on a national inquiry by the Public Health Laboratory Service in collaboration with the Society of Medical Officers of Health Br Med J 5401 1964 75-78
2. C.L. Miller Severity of notified measles Br Med J 1 6122 1978 1253
3. OPCS The Registrar General's Statistical Review of England and Wales for the Year 1969 1971 HMSO London
4. C.M. Beard R.C. Benson Jr. P.P. Kelalis L.R. Elveback L.T. Kurland The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974 Mayo Clin Proc 52 1 1977 3-7
5. N.S. Galbraith S.E. Young J.J. Pusey D.L. Crombie J.P. Sparks Mumps surveillance in England and Wales 1962-1981 Lancet 1 8368 1984 91-94
6. W.L. Atkinson S.C. Hadler S.B. Redd W.A. Orenstein Measles surveillance-United States, 1991 MMWR CDC Surveill Summ 41 6 1992 1-12
7. S. van den Hof C.M. Meffre M.A. Conyn-van Spaendonck F. Woonink H.E. de Melker R.S. van Binnendijk Measles outbreak in a community with very low vaccine coverage, the Netherlands Emerg Infect Dis 7 3 Suppl 2001 593-597
8. J.A. van Druten T. de Boo A.D. Plantinga Measles, mumps and rubella: control by vaccination Dev Biol Stand 65 1986 53-63
9. T. Panagiotopoulos I. Antoniadou E. Valassi-Adam Increase in congenital rubella occurrence after immunisation in Greece: Retrospective survey and systematic review BMJ 319 7223 1999 1462-1467
10. World Health Organization. Measles vaccine. Vaccines, Immunization and Biologicals. 2002. Available from: http://www.who.int/vaccine_research/diseases/measles/en/ (accessed 13/5/04).
11. World Health Organization. Mumps vaccine. Vaccines, Immunization and Biologicals. 2004. Available from: http://www.who.int/vaccines-diseases/diseases/mumps_vaccine.shtml (accessed 13/5/04).
12. World Health Organization. Rubella vaccine. Vaccines, Immunization and Biologicals. 2004. Available from: http://www.who.int/vaccines/en/rubella.shtml (accessed 13/5/04)
13. V.F. Guinee D.A. Henderson H.L. Casey S.T. Wingo D.W. Ruthig T.A. Cockburn et al Cooperative measles vaccine field trial. I. Clinical efficacy Pediatrics 37 4 1966 649-665
14. Vaccination against measles: Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Second report to the medical research council by the measles vaccines committee. Br Med J 1968; 2(603):449-452.
15. J.S. Pagano R.H. Levine W.C. Sugg J.A. Finger Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): Preliminary report Prog Immunobiol Stand 3 1969 196-202
16. W.C. Sugg J.A. Finger R.H. Levine J.S. Pagano Field evaluation of live virus mumps vaccine J Pediatr 72 4 1968 461-466
17. R.P. Beasley R. Detels K.S. Kim J.L. Gale T.L. Lin J.T. Grayston Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines Am J Dis Child 118 2 1969 301-306
18. D.A. Salmon M. Haber E.J. Gangarosa L. Phillips N.J. Smith R.T. Chen Health consequences of religious and philosophical exemptions from immunization laws: Individual and societal risk of measles JAMA 282 1 1999 47-53
19. N. Gay E. Miller L. Hesketh P. Morgan-Capner M. Ramsay et al Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule Commun Dis Rep CDR Rev 7 2 1997 R21-R26
20. M. Schlegel J.J. Osterwalder R.L. Galeazzi P.L. Vernazza Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: Cohort study BMJ 319 1999 352
21. P. Tookey Rubella in England, Scotland and Wales Eurosurveillance Monthly 9 4 2004 21-22
22. H. Peltola O.P. Heinonen M. Valle M. Paunio M. Virtanen et al The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program N Engl J Med 331 21 1994 1397-1402
23. Centers for Disease Control. Measles epidemic attributed to inadequate vaccination coverage-Campania, Italy, 2002. MMWR Morb Mortal Wkly Rep 2003;52(43):1044-1047.
24. J. McBrien J. Murphy D. Gill M. Cronin C. O'Donovan M.T. Cafferkey Measles outbreak in Dublin, 2000 Pediatr Infect Dis J 22 7 2003 580-584
25. Siedler A. Measles outbreaks in Germany. Eurosurveillance Weekly http://www.eurosurveillance.org/ew/2002/020321.asp 6(12). 21-3-2002.
26. H.J. Schmitt R. Booy C. Weil-Olivier P. Van Damme R. Cohen H. Peltola Child vaccination policies in Europe: A report from the Summits of Independent European Vaccination Experts Lancet Infect Dis 3 2 2003 103-108
27. V.A. Jansen N. Stollenwerk H.J. Jensen M.E. Ramsay W.J. Edmunds C.J. Rhodes Measles outbreaks in a population with declining vaccine uptake Science 301 5634 2003 804
28. Health Protection Agency. Completed Primary Courses at Two Years of Age: England and Wales, 1966-1977, England only 1978. 2004. Available from: Available from: http://www.hpa.org.uk/infections/topics_az/vaccination/ vac_cover.htm (accessed 13/5/04)
29. A. Ekbom A.J. Wakefield M. Zack H.O. Adami Perinatal measles infection and subsequent Crohn's disease Lancet 344 8921 1994 508-510
30. N.P. Thompson S.M. Montgomery R.E. Pounder A.J. Wakefield Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 345 8957 1995 1071-1074
31. D.S. Pardi W.J. Tremaine W.J. Sandborn E.V. Loftus Jr. G.A. Poland L.J. Melton III Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease Inflamm Bowel Dis 5 2 1999 104-106
32. M. Feeney A. Ciegg P. Winwood J. Snook A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group Lancet 350 9080 1997 764-766
33. D.L. Morris S.M. Montgomery N.P. Thompson S. Ebrahim R.E. Pounder A.J. Wakefield Measles vaccination and inflammatory bowel disease: A national British Cohort Study Am J Gastroenterol 95 12 2000 3507-3512
34. A.J. Wakefield S.H. Murch A. Anthony J. Linnell D.M. Casson M. Malik Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 351 9103 1998 637-641
35. R.T. Chen F. DeStefano Vaccine adverse events: Causal or coincidental? Lancet 351 9103 1998 611-612
36. H. Peltola A. Patja P. Leinikki M. Valle I. Davidkin M. Paunio No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study Lancet 351 9112 1998 1327-1328
37. B. Taylor E. Miller C.P. Farrington M.C. Petropoulos I. Favot-Mayaud J. Li et al Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association Lancet 353 9169 1999 2026-2029
38. A. Patja I. Davidkin T. Kurki M.J. Kallio M. Valle H. Peltola Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up Pediatr Infect Dis J 19 12 2000 1127-1134
39. J.A. Kaye M. Mar Melero-Montes H. Jick Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis BMJ 322 7284 2001 460-463
40. L. Dales S.J. Hammer N.J. Smith Time trends in autism and in MMR immunization coverage in California JAMA 285 9 2001 1183-1185
41. C.P. Farrington E. Miller B. Taylor MMR and autism: Further evidence against a causal association Vaccine 19 27 2001 3632-3635
42. K.M. Madsen A. Hviid M. Vestergaard D. Schendel J. Wohlfahrt P. Thorsen et al A population-based study of measles, mumps, and rubella vaccination and autism N Engl J Med 347 19 2002 1477-1482
43. Institute of Medicine. Immunization Safety Review: Vaccines and Autism. 12-6-2004. Washington DC, National Academy Press. Available from: http://www.nap.edu/books/030909237X/html/ (accessed 12.6.04).
44. V. Uhlmann C.M. Martin O. Sheils L. Pilkington I. Silva A. Killalea et al Potential viral pathogenic mechanism for new variant inflammatory bowel disease Mol Pathol 55 2 2002 84-90
45. C.M. Martin V. Uhlmann A. Killalea O. Sheils J.J. O'Leary Detection of measles virus in children with ileo-colonic lymphoid nodular hyperplasia, enterocolitis and developmental disorder Mol Psychiatry 7 Suppl 2 2002 S47-S48
46. A. Morris D. Aldulaimi New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder? Mol Pathol 55 2 2002 83
47. M. Petrovic R. Roberts M. Ramsay Second dose of measles, mumps, and rubella vaccine: Questionnaire survey of health professionals BMJ 322 7278 2001 82-85
48. M.S. Smailbegovic G.J. Laing H. Bedford Why do parents decide against immunization? The effect of health beliefs and health professionals Child Care Health Dev 29 4 2003 303-311
49. Harrabin R, Coote A, Allen J. Health in the News. Risk reporting and media influence. London: King's Fund; 2003.
50. I. Hargreaves LJST Towards a better map: Science, the public and the media 2003 Economic & Social Research Council Swindon
51. H. Bedford J. Moreton D. Elliman MMR vaccine: Are health professionals missing the point? Community Practitioner 73 4 2002 100-103
52. S.H. Murch A. Anthony D.H. Casson M. Malik M. Berelowitz A.P. Dhillon M.A. Thomson A. Valentine S.E. Davies J.A. Walker-Smith Retraction of an interpretation Lancet 363 941 2004 750